The Valley Desk

NCT04844606 · Interventional trial

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

Overall registry status Recruiting

Phase 3

Conditions Crohn's Disease, Inflammatory Bowel Diseases, Ulcerative Colitis, Ulcerative Colitis Chronic

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov